ATE527996T1 - Medizinische verwendung von 3-(2,2,2- trimethylhydrazinium)propionat-orotat - Google Patents

Medizinische verwendung von 3-(2,2,2- trimethylhydrazinium)propionat-orotat

Info

Publication number
ATE527996T1
ATE527996T1 AT08170584T AT08170584T ATE527996T1 AT E527996 T1 ATE527996 T1 AT E527996T1 AT 08170584 T AT08170584 T AT 08170584T AT 08170584 T AT08170584 T AT 08170584T AT E527996 T1 ATE527996 T1 AT E527996T1
Authority
AT
Austria
Prior art keywords
trimethylhydrazinium
medical use
orotate
propionate
propionate orotate
Prior art date
Application number
AT08170584T
Other languages
English (en)
Inventor
Ivars Kalvins
Reinis Vilskersts
Edgars Liepins
Maija Dambrova
Anatolijs Birmans
Original Assignee
Grindeks Jsc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Grindeks Jsc filed Critical Grindeks Jsc
Application granted granted Critical
Publication of ATE527996T1 publication Critical patent/ATE527996T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT08170584T 2007-12-12 2008-12-03 Medizinische verwendung von 3-(2,2,2- trimethylhydrazinium)propionat-orotat ATE527996T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP07122978 2007-12-12

Publications (1)

Publication Number Publication Date
ATE527996T1 true ATE527996T1 (de) 2011-10-15

Family

ID=39032080

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08170584T ATE527996T1 (de) 2007-12-12 2008-12-03 Medizinische verwendung von 3-(2,2,2- trimethylhydrazinium)propionat-orotat

Country Status (3)

Country Link
EP (1) EP2070529B1 (de)
AT (1) ATE527996T1 (de)
WO (1) WO2009074498A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201102659D0 (en) 2011-02-15 2011-03-30 Isis Innovation Assay
BR112013027065B1 (pt) * 2011-04-27 2019-12-03 Grindeks Jsc processo para a preparação de sais de 3-carboxi-n-etil-n,n-dimetilpropan-1amínio, compostos e seus usos
GB201113101D0 (en) 2011-07-28 2011-09-14 Isis Innovation Assay
RU2467748C1 (ru) * 2011-08-08 2012-11-27 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Белгородский государственный национальный исследовательский университет" Производное 3-(2,2,2-триметилгидразиний)пропионата - глицинат 3-(2,2,2-триметилгидразиний)пропионат калия, обладающее эндотелиопротекторной активностью

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU997646A1 (ru) 1978-11-27 1983-02-23 Ордена Трудового Красного Знамени Институт Органического Синтеза Ан Латвсср Кормова добавка
IT1210935B (it) * 1981-09-17 1989-09-29 Inst Orch Sinteza Akademi Nauk Composizione farmaceutica per il trattamento di malattie cardiovascolari.
DE19530278A1 (de) 1995-08-17 1997-02-20 Woerwag Pharma Gmbh Verwendung von Orotsäure zur Prävention und/oder Therapie des Remodelling bei Patienten mit akutem Infarkt
MXPA06000955A (es) 2003-08-04 2006-03-30 Grindeks Jsc Sales de meldonio, metodo para su preparacion y composiciones farmaceuticas basadas en ellas.

Also Published As

Publication number Publication date
EP2070529B1 (de) 2011-10-12
EP2070529A1 (de) 2009-06-17
WO2009074498A8 (en) 2010-06-24
WO2009074498A1 (en) 2009-06-18

Similar Documents

Publication Publication Date Title
LTC2137143I2 (lt) Pleuromutilino dariniai, skirti mikrobų sukeltų ligų gydymui
EA200701471A1 (ru) Замещённые пиридинильные и пиримидинильные производные, используемые в качестве модуляторов метаболизма и лечение ассоциированных с ним расстройств
EA201071243A1 (ru) Комбинированные композиции для лечения болезни альцгеймера и родственных заболеваний зонизамидом и акампросатом
EA201071045A1 (ru) Соединения оксадиазоантрацена для лечения диабета
EA200900623A1 (ru) Бициклические соединения и их применение в качестве противодиабетических средств
MA32811B1 (fr) Nouveaux composés
EA201071245A1 (ru) Новые терапевтические подходы для лечения болезни альцгеймера и связанных нарушений посредством модулирования реакции клеток на стресс
CY1113665T1 (el) Θετικοι αλλοστερικοι ρυθμιστες του υποδοχεα μ1 με αρυλομεθυλο βενζοκιναζολινονη
EA200900136A1 (ru) Пирролопиримидины для фармацевтических композиций
GEP20156216B (en) Heterocyclic compound and usage thereof
EA201000098A1 (ru) Производные хиназолинамида
NO20082096L (no) Azaindol-2-karboksamidderivativer
EA201500403A1 (ru) Соединения, активирующие теломеразу, и способы их применения
MA32505B1 (fr) 5-alcynyl-pyrimidines
ATE541832T1 (de) Neuartige p2x7r-antagonisten und ihre verwendung
EA201100872A1 (ru) Производные хиназолинамида
NO20075368L (no) Antiinflammatoriske modaliteter
ATE523495T1 (de) Substituierte pyrazolinverbindungen, deren herstellung und verwendung als medikamente
ATE527996T1 (de) Medizinische verwendung von 3-(2,2,2- trimethylhydrazinium)propionat-orotat
UA110332C2 (en) Use of 2,3-dihydroxypropyldodecanoate for treatment of seborrhea
ATE449776T1 (de) Pyrroloä2,3-cüpyridinderivate
EA201200855A1 (ru) Модуляторы crth2
DE502006008804D1 (de) Neue, langwirksame betamimetika zur behandlung von atemwegserkrankungen
EA200702336A1 (ru) ПРИМЕНЕНИЕ 24-норУДХК
ATE481395T1 (de) Cyclohexylderivate

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties